Advances in prevention and treatment of cerebral palsy

Mario Petersen, Frederick B. Palmer

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

In recent years there have been a number of advances in understanding of predisposing and protective factors in the development of cerebral palsy in infants. Multiple gestation births, maternal infection, and maternal and fetal thrombophilic conditions all predispose to the development of CP in the infant. Opportunities for prevention of CP may develop from an improved understanding of these factors and their mechanisms of operation. Similar progress has been made in the evaluation of treatments for CP and the effects of these treatments on the individual's impairment, function, and disability. Selective posterior rhizotomy and Botulinum toxin A are now widely used in the treatment of spasticity. The challenge remains to determine how effectively these promising interventions can alter long-term function and quality of life outcomes in children and adults with CP.

Original languageEnglish (US)
Pages (from-to)30-37
Number of pages8
JournalMental Retardation and Developmental Disabilities Research Reviews
Volume7
Issue number1
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Cerebral Palsy
Mothers
Rhizotomy
Multiple Birth Offspring
Type A Botulinum Toxins
Causality
Therapeutics
Quality of Life
Pregnancy
Infection

Keywords

  • Cerebral palsy
  • CP
  • Risk
  • Thrombophilia
  • Treatment of spasticity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Neuropsychology and Physiological Psychology
  • Genetics(clinical)

Cite this

Advances in prevention and treatment of cerebral palsy. / Petersen, Mario; Palmer, Frederick B.

In: Mental Retardation and Developmental Disabilities Research Reviews, Vol. 7, No. 1, 2001, p. 30-37.

Research output: Contribution to journalArticle

@article{dd9b6e3b9634416c9c47df8d1cc6f967,
title = "Advances in prevention and treatment of cerebral palsy",
abstract = "In recent years there have been a number of advances in understanding of predisposing and protective factors in the development of cerebral palsy in infants. Multiple gestation births, maternal infection, and maternal and fetal thrombophilic conditions all predispose to the development of CP in the infant. Opportunities for prevention of CP may develop from an improved understanding of these factors and their mechanisms of operation. Similar progress has been made in the evaluation of treatments for CP and the effects of these treatments on the individual's impairment, function, and disability. Selective posterior rhizotomy and Botulinum toxin A are now widely used in the treatment of spasticity. The challenge remains to determine how effectively these promising interventions can alter long-term function and quality of life outcomes in children and adults with CP.",
keywords = "Cerebral palsy, CP, Risk, Thrombophilia, Treatment of spasticity",
author = "Mario Petersen and Palmer, {Frederick B.}",
year = "2001",
doi = "10.1002/1098-2779(200102)7:1<30::AID-MRDD1005>3.0.CO;2-2",
language = "English (US)",
volume = "7",
pages = "30--37",
journal = "Mental Retardation and Developmental Disabilities Research Reviews",
issn = "1080-4013",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Advances in prevention and treatment of cerebral palsy

AU - Petersen, Mario

AU - Palmer, Frederick B.

PY - 2001

Y1 - 2001

N2 - In recent years there have been a number of advances in understanding of predisposing and protective factors in the development of cerebral palsy in infants. Multiple gestation births, maternal infection, and maternal and fetal thrombophilic conditions all predispose to the development of CP in the infant. Opportunities for prevention of CP may develop from an improved understanding of these factors and their mechanisms of operation. Similar progress has been made in the evaluation of treatments for CP and the effects of these treatments on the individual's impairment, function, and disability. Selective posterior rhizotomy and Botulinum toxin A are now widely used in the treatment of spasticity. The challenge remains to determine how effectively these promising interventions can alter long-term function and quality of life outcomes in children and adults with CP.

AB - In recent years there have been a number of advances in understanding of predisposing and protective factors in the development of cerebral palsy in infants. Multiple gestation births, maternal infection, and maternal and fetal thrombophilic conditions all predispose to the development of CP in the infant. Opportunities for prevention of CP may develop from an improved understanding of these factors and their mechanisms of operation. Similar progress has been made in the evaluation of treatments for CP and the effects of these treatments on the individual's impairment, function, and disability. Selective posterior rhizotomy and Botulinum toxin A are now widely used in the treatment of spasticity. The challenge remains to determine how effectively these promising interventions can alter long-term function and quality of life outcomes in children and adults with CP.

KW - Cerebral palsy

KW - CP

KW - Risk

KW - Thrombophilia

KW - Treatment of spasticity

UR - http://www.scopus.com/inward/record.url?scp=0035106064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035106064&partnerID=8YFLogxK

U2 - 10.1002/1098-2779(200102)7:1<30::AID-MRDD1005>3.0.CO;2-2

DO - 10.1002/1098-2779(200102)7:1<30::AID-MRDD1005>3.0.CO;2-2

M3 - Article

C2 - 11241880

AN - SCOPUS:0035106064

VL - 7

SP - 30

EP - 37

JO - Mental Retardation and Developmental Disabilities Research Reviews

JF - Mental Retardation and Developmental Disabilities Research Reviews

SN - 1080-4013

IS - 1

ER -